References
- PathakKRaghuvanshiSOral bioavailability: issues and solutions via nanoformulationsClin Pharmacokinet201554432535725666353
- CastroPMFontePSousaFMadureiraARSarmentoBPintadoMEOral films as breakthrough tools for oral delivery of proteins/peptidesJ Control Release2015211637325979328
- HardeHDasMJainSSolid lipid nanoparticles: an oral bioavailability enhancer vehicleExpert Opin Drug Deliv20118111407142421831007
- GamazoCMartin-ArbellaNBrotonsACamachoAIIracheJMMimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunizationEur J Pharm Biopharm20159645446325615880
- VieiraACFerreira FontesDAChavesLLMulticomponent systems with cyclodextrins and hydrophilic polymers for the delivery of EfavirenzCarbohydr Polym201513013314026076609
- MeiLZhangZZhaoLPharmaceutical nanotechnology for oral delivery of anticancer drugsAdv Drug Deliv Rev201365688089023220325
- SigurdssonHHKirchJLehrC-MMucus as a barrier to lipophilic drugsInt J Pharm20134531566423727593
- ChavesLLVieiraACFerreiraDSarmentoBReisSRational and precise development of amorphous polymeric systems with dapsone by response surface methodologyInt J Biol Macromol20158166267126314903
- ChenM-CSonajeKChenK-JSungH-WA review of the prospects for polymeric nanoparticle platforms in oral insulin deliveryBiomaterials201132369826983821925726
- des RieuxAPourcelleVCaniPDMarchand-BrynaertJPréatVTargeted nanoparticles with novel non-peptidic ligands for oral deliveryAdv Drug Deliv Rev201365683384423454185
- AraújoFPereiraCCostaJBarriasCGranjaPLSarmentoBIn vitro M-like cells genesis through a tissue-engineered triple-culture intestinal modelJ Biomed Mater Res B: Appl Biomater2016105478278826313639
- MabbottNADonaldsonDSOhnoHWilliamsIRMahajanAMicrofold (M) cells: important immunosurveillance posts in the intestinal epitheliumMucosal Immunol20136466667723695511
- WitoonsaridsilpWPaeratakulOPanyarachunBSarisutaNDevelopment of mannosylated liposomes using synthesized N-octadecyl-d-mannopyranosylamine to enhance gastrointestinal permeability for protein deliveryAAPS PharmSciTech201213269970622562613
- DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
- KawakamiSHashidaMGlycosylation-mediated targeting of carriersJ Control Release201419054255524915504
- LokaRSMcConnellMSNguyenHMStudies of highly-ordered heterodiantennary mannose/glucose-functionalized polymers and concanavalin a protein interactions using isothermal titration calorimetryBiomacromolecules201516124013402126580410
- IracheJMSalmanHHGamazoCEspuelasSMannose-targeted systems for the delivery of therapeuticsExpert Opin Drug Deliv20085670372418532925
- YoungrenSRMulikRJunBHoffmannPRMorrisKRChouguleMBFreeze-dried targeted mannosylated selenium-loaded nanoliposomes: development and evaluationAAPS PharmSciTech20131431012102423797303
- LuoYTengZLiYWangQSolid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptakeCarbohydr Polym201512222122925817662
- KizhakkedathuJNCreaghALShenoiRAHigh molecular weight polyglycerol-based multivalent mannose conjugatesBiomacromolecules201011102567257520804173
- NakatoGHaseKSuzukiMCutting edge: Brucella abortus exploits a cellular prion protein on intestinal M cells as an invasive receptorJ Immunol201218941540154422772447
- KimHJBrennanPJHeaslipDUdeyMCModlinRLBelisleJTCarbohydrate-dependent binding of langerin to SodC, a cell wall glycoprotein of Mycobacterium lepraeJ Bacteriol2015197361562525422308
- BhatRMPrakashCLeprosy: an overview of pathophysiologyInterdiscip Perspect Infect Dis2012201218108922988457
- KarHKGuptaRTreatment of leprosyClin Dermatol2015331556525432811
- EichelmannKGonzálezSGSalas-AlanisJOcampo-CandianiJLeprosy. An update: definition, pathogenesis, classification, diagnosis, and treatmentActas Dermosifiliogr2013104755456323870850
- YamasakiPRdo NascimentoDCChelucciRCSynthesis and evaluation of novel dapsone-thalidomide hybrids for the treatment of type 2 leprosy reactionsBioorg Med Chem Lett201424143084308724907144
- AnusuyaSNatarajanJThe eradication of leprosy: molecular modeling techniques for novel drug discoveryExpert Opin Drug Discov20138101239125123924296
- WijagkanalanWKawakamiSTakenagaMIgarashiRYamashitaFHashidaMEfficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in ratsJ Control Release2008125212113018037185
- WangTZhenYMaXWeiBLiSWangNMannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chainColloids Surf B Biointerfaces201512652053025612819
- KumarPVAsthanaADuttaTJainNKIntracellular macrophage uptake of rifampicin loaded mannosylated dendrimersJ Drug Target200614854655617050121
- DuttaTAgasheHBGargMBalakrishnanPKabraMJainNKPoly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitroJ Drug Target2007151899817365278
- DuttaTJainNKTargeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimerBiochim Biophys Acta20071770468168617276009
- GuoYLiuXSunXZhangQGongTZhangZMannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific deliveryTheranostics20122111104111423227126
- Thomann-HarwoodLJKaeuperPRossiNMilonaPHerrmannBMcCulloughKCNanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activationJ Control Release201316629510523220107
- ChuanJLiYYangLEnhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticlesJ Nanopart Res201315519
- SongXLinQGuoLRifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific deliveryPharm Res20153251741175125407545
- SalmanHHGamazoCCampaneroMAIracheJMBioadhesive mannosylated nanoparticles for oral drug deliveryJ Nanosci Nanotechnol2006693203320917048537
- VenishettyVKChedeRKomuravelliRAdepuLSistlaRDiwanPVDesign and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administrationColloids Surf B: Biointerfaces2012951922463845
- ChoHJParkJWYoonISKimDDSurface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptakeInt J Nanomedicine2014949550424531717
- Aji AlexMRChackoAJJoseSSoutoEBLopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targetingEur J Pharm Sci2011421–2111820971188
- JainAAgarwalAMajumderSMannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drugJ Control Release2010148335936720854859
- PintoMFMouraCCNunesCSegundoMACosta LimaSAReisSA new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriersInt J Pharm20144771–251952625445970
- KalamMASultanaYAliAAqilMMishraAKChuttaniKPreparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery systemJ Drug Target201018319120419839712
- DasSNgWKKanaujiaPKimSTanRBHFormulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variablesColloids Surf B Biointerfaces201188148348921831615
- ShahBKhuntDBhattHMisraMPadhHApplication of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parametersEur J Pharm Sci201578546626143262
- ChavesLLRolimLAGonçalvesMLStudy of stability and drug-excipient compatibility of diethylcarbamazine citrateJ Thermal Anal Calorim2013111321792186
- LiYTaulierNRauthAWuXScreening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN)Pharm Res20062381877188716850265
- ShahRMMalherbeFEldridgeDPalomboEAHardingIHPhysicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion techniqueJ Colloid Interface Sci201442828629424910064
- AraújoFShresthaNShahbaziM-AThe impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epitheliumBiomaterials201435339199920725109441
- FattahpourSShamanianMTavakoliNFathiMSheykhiSRFattahpourSDesign and optimization of alginate – chitosan − pluronic nanoparticles as a novel meloxicam drug delivery systemJ Appl Polym Sci20151322842241
- das NevesJSarmentoBPrecise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicidesActa Biomater201518778725700657
- RahmanZZidanASHabibMJKhanMAUnderstanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman designInt J Pharm20103891–218619420038446
- TaurozziJSHackleyVAWiesnerMRUltrasonic dispersion of nanoparticles for environmental, health and safety assessment – issues and recommendationsNanotoxicology20115471172921073401
- BhupinderSRishiKMousumiNNaveenADeveloping oral drug delivery systems using formulation by design: vital precepts, retrospect and prospectsExpert Opin Drug Deliv20118101341136021790511
- NevesARLúcioMMartinsSLimaJLCReisSNovel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailabilityInt J Nanomedicine2013817718723326193
- SilvaACGonzalez-MiraEGarciaMLPreparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasoundColloids Surf B Biointerfaces201186115816521530187
- ChaubeyPMishraBMannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasisCarbohydr Polym20141011101110824299880
- CostaEdSJrMansurHSPreparation and characterization of chitosan/poly(vinyl alcohol)blend chemically crosslinked by glutaraldehyde for tissue engineering applicationQuímica Nova20083114601466 Portuguese
- MüllerRHRungeSARavelliVThünemannAFMehnertWSoutoEBCyclosporine-loaded solid lipid nanoparticles (SLN®): Drug–lipid physicochemical interactions and characterization of drug incorporationEur J Pharm Biopharm200868353554417804210
- GokceEHKorkmazEDelleraESandriGBonferoniMCOzerOResveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applicationsInt J Nanomedicine201271841185022605933
- GuadaMSebastiánVIrustaSFeijoóEDios-Viéitez MdelCBlanco-PrietoMJLipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activityInt J Nanomedicine2015106541655326527872
- MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
- HeCYinLTangCYinCSize-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugsBiomaterials201233338569857822906606
- ÜnerMYenerGImportance of solid lipid nanoparticles (SLN) in various administration routes and future perspectivesInt J Nanomedicine20072328930018019829
- SiramKChellanVRNatarajanTSolid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluationExpert Opin Drug Deliv20141191351136524847779
- MishraAVuddandaPRSinghSIntestinal lymphatic delivery of praziquantel by solid lipid nanoparticles: formulation design, in vitro and in vivo studiesJ Nanotechnol20142014112